CYTEK BIOSCIENCES INC (CTKB) Stock Income Statement
NASDAQ:CTKB • US23285D1090
Current stock price
4.01 USD
+0.01 (+0.25%)
At close:
4.01 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 201.49M | 200.45M | 193.01M | 164.00M | 128.00M | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 100.00K | 0.00 | |||
| Cost Of Goods | 97.03M | 89.35M | 83.59M | 63.10M | 48.80M | |||
| Gross Profit | 104.46M | 111.11M | 109.43M | 101.00M | 79.10M | |||
| Operating Expenses | 144.84M | 131.63M | 137.27M | 102.70M | 69.80M | |||
| Research and Development | 36.47M | 39.40M | 44.15M | 34.90M | 24.40M | |||
| Selling, General, and Administrative Expenses | 108.38M | 92.23M | 93.12M | 67.90M | 45.30M | |||
| Operating Income | -40.38M | -20.52M | -27.84M | -1.80M | 9.40M | |||
| Interest Income/Expense | 1.70M | 10.32M | 4.30M | 2.00M | -1.70M | |||
| Other Income/Expense | 8.84M | 4.50M | 7.83M | 1.10M | -1.50M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -200.00K | |||
| Income Before Taxes | -29.84M | -5.70M | -15.71M | 1.30M | 5.90M | |||
| Income Tax | 36.70M | 320.00K | -3.56M | -1.20M | 2.90M | |||
| Net Income | -66.54M | -6.02M | -12.15M | 2.60M | 0.00 | |||
| EBITDA | -32.80M | -13.31M | -21.80M | 690.00K | 10.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.52 | -0.05 | -0.09 | 0.02 | 0.00 | |||
| Non GAAP EPS | -0.21 | -0.05 | 0.05 | 0.14 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 51.84% | 55.43% | 56.69% | 61.59% | 61.80% | |||
| Profit Margin | -33.02% | -3.00% | -6.29% | 1.59% | N/A | |||
| Operating Profit Margin | -20.04% | -10.24% | -14.43% | -1.10% | 7.34% | |||
All data in USD